CRISPR-U™ Gene Knockout Cell Line Strategy

BST2 Gene Knockout Strategy

CRISPR-U™ technology (CRISPR based), developed by Ubigene, is more efficient than general CRISPR/Cas9 technology in double-strand breaking and homologous recombination. With CRISPR-U™, Ubigene has successfully edited over 3000 genes on more than 100 types of cell lines.
Objective
To create a Human BST2 Knockout model in cell line by CRISPR-U™-mediated genome engineering.
Target gene info
Official symbol BST2
Gene id 684
Organism Homo sapiens
Official full symbol bone marrow stromal cell antigen 2
Gene type protein-coding
Also known as CD317, TETHERIN
Summary Bone marrow stromal cells are involved in the growth and development of B-cells. The specific function of the protein encoded by the bone marrow stromal cell antigen 2 is undetermined; however, this protein may play a role in pre-B-cell growth and in rheumatoid arthritis.
Genomic regions Chromosome 19
Strategy Summary
This gene has 1 protein coding transcripts:
Name Transcript ID bp Protein Biotype CCDS UniProt Match RefSeq Match Flags
BST2-201 ENST00000252593.7 1001 180aa Protein coding CCDS12358 Q10589-1 NM_004335.4 TSL:1, GENCODE basic, APPRIS P1, MANE Select v0.92,
BST2-202 ENST00000527220.2 879 100aa Nonsense mediated decay - - - TSL:2,
BST2-203 ENST00000533098.5 459 No protein Retained intron - - - TSL:2,
Ubigene Red Cotton Transcript
Strategy Click to get
Red Cotton™ Assessment    
Project Difficulty Level unknown
Target Gene BST2
This KO Strategy loading
Red Cotton™ Notes Gene BST2 had been KO in hela cell line.
Aforementioned information comes from Ubigene database. Different origin of cell lines may have different condition. Ubigene reserved all the right for final explanation.
Special deals for this gene:

$49

Single gRNA plasmid off-shelf

$599

Single gRNA lentivirus

Work flow
Ubigene Red Cotton Workflow

Please leave your suggestion ×

Comment: